Influenza News and Research

Latest Influenza News and Research

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Vaccines can be made over 25% more effective by adding left-handed chiral gold nanoparticles as adjuvants, according to a study by an international collaboration in which Brazilian researchers took part. An article reporting the results is published in Nature.

18 Apr 2022

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Researchers assessed the effectiveness of COVID-19 vaccines against related hospitalizations and death.

18 Apr 2022

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Researchers reviewed the antibody resistance exhibited by SARS-CoV-2 variants.

18 Apr 2022

SARS-CoV-2 RBD is a selective integrin agonist

Researchers assess the Arg-Gly-Asp (RGD) motif-mediated binding of the SARS-CoV-2 RBD and integrin receptors.

18 Apr 2022

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Researchers assessed the protective efficacy of the temperature-stable orally delivered vaccines against respiratory viral pathogens.

14 Apr 2022

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

In a recent study, researchers assessed the anti-COVID-19 efficacy of Salvia miltiorrhiza Bunge.

14 Apr 2022

Additional booster doses of COVID-19 vaccine help protect solid organ transplant recipients

Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows.

13 Apr 2022

AI can help identify which symptoms are more likely to indicate COVID during flu season

Testing shortages, long waits for results, and an over-taxed health care system have made headlines throughout the COVID-19 pandemic.

13 Apr 2022

Study determines hemagglutinin inhibition seroprevalence against swine influenza viruses circulating in Hong Kong and Guangzhou

Researchers performed a quantitative assessment of the age-stratified seroprevalence of hemagglutination inhibition antibodies against five swine influenza viruses circulating in the Guangzhou and Hong Kong cities of China.

13 Apr 2022

Study explores myopericarditis incidence and COVID-19 vaccination

Researchers investigated the impact of COVID-19 vaccination on the incidence of myopericarditis.

13 Apr 2022

The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

In a new study, researchers devised a method for reducing the size of a large collection of SARS-CoV-2 genomes by combining correlated single nucleotide variation sets with allelic association.

13 Apr 2022

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

The overall risk of myopericarditis following COVID-19 vaccination is very low, affecting 18 people per million vaccine doses. A new study published in The Lancet Respiratory Medicine, confirms that this risk is comparable to or lower following COVID-19 vaccination than other non-COVID-19 vaccines.

13 Apr 2022

Experimental tool can precisely pick out interactions between immune cell and target antigen

The human body has millions of unique B and T cells that roam the body, looking for microbial invaders. These immune cells' ability to recognize harmful microbes is critical to successfully fighting off infection.

12 Apr 2022

SARS-CoV-2 mutations change proteasome processing to alter CD8+ T cell responses

Researchers identified mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoproteins (NP) epitope flanking regions and their potential effects on CD8+ T cell activation.

12 Apr 2022

New study reveals oral opaganib's potent in vitro activity against Omicron

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced study results in which opaganib (ABC294640), a leading oral drug candidate for hospitalized patients with moderate to severe COVID-19, was observed to have potent in vitro efficacy against the Omicron SARS-CoV-2 variant, while maintaining host cell viability.

11 Apr 2022

COVID-19 vaccines and reports of menstrual disorders

A new study estimates the potential relationship between COVID-19 vaccines and menstrual disorders.

11 Apr 2022

Impact of cardiovascular disease in pregnant or postpartum COVID-19 patients

In a recent study posted to the medRxiv* preprint server, researchers reported coronavirus disease 2019 (COVID-19) prognosis worsened by the presence of cardiovascular diseases (CVDs) in pregnant and postpartum women.

11 Apr 2022

SARS-CoV-2 Delta-Omicron recombinant identified in a transplant patient treated with Sotrovimab

Researchers described a case of co-infection with SARS-CoV-2 variants of concern, Delta and Omicron.

8 Apr 2022

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

A recent study posted to the medRxiv* preprint server investigated the elements that predicted all-cause mortality among individuals hospitalized due to influenza, respiratory syncytial virus (RSV), or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

7 Apr 2022

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

A new preprint study depicted the generation of self-assembling coronavirus disease 2019 (COVID-19) nanoparticle vaccines.

6 Apr 2022

Influenza News and Research

Latest Influenza News and Research

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

SARS-CoV-2 RBD is a selective integrin agonist

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

Additional booster doses of COVID-19 vaccine help protect solid organ transplant recipients

AI can help identify which symptoms are more likely to indicate COVID during flu season

Study determines hemagglutinin inhibition seroprevalence against swine influenza viruses circulating in Hong Kong and Guangzhou

Study explores myopericarditis incidence and COVID-19 vaccination

The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

Experimental tool can precisely pick out interactions between immune cell and target antigen

SARS-CoV-2 mutations change proteasome processing to alter CD8+ T cell responses

New study reveals oral opaganib's potent in vitro activity against Omicron

COVID-19 vaccines and reports of menstrual disorders

Impact of cardiovascular disease in pregnant or postpartum COVID-19 patients

SARS-CoV-2 Delta-Omicron recombinant identified in a transplant patient treated with Sotrovimab

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in